Cargando…
Oncogenic c-terminal cyclin D1 (CCND1) mutations are enriched in endometrioid endometrial adenocarcinomas
Cyclin D1 (CCND1) is a core cell cycle regulator and is frequently overexpressed in human cancers, often via amplification, translocation or post-transcription regulation. Accumulating evidence suggests that mutations of the CCND1 gene that result in nuclear retention and constitutive activation of...
Autores principales: | Xu, Jia, Lin, Douglas I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029777/ https://www.ncbi.nlm.nih.gov/pubmed/29969496 http://dx.doi.org/10.1371/journal.pone.0199688 |
Ejemplares similares
-
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
por: Adélaide, J., et al.
Publicado: (1995) -
RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
por: Liu, Shuang, et al.
Publicado: (2019) -
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017) -
Improved survival associated with somatic PIK3CA mutations in copy-number low endometrioid endometrial adenocarcinoma
por: LIN, DOUGLAS I.
Publicado: (2015) -
The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
por: Tsuda, H, et al.
Publicado: (2000)